Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC

Clinical trial NCT07177105 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07177105
Sponsor: Jianxing He
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2025-09-10
Primary completion: 2028-10-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.